| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,417 |
2,310 |
$173K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,452 |
2,315 |
$131K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,169 |
1,167 |
$106K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,203 |
1,199 |
$77K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,246 |
1,178 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
347 |
331 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
679 |
677 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
625 |
326 |
$8K |
| 99000 |
|
2,154 |
2,040 |
$6K |
| 87428 |
|
159 |
158 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
119 |
115 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
31 |
31 |
$2K |
| 99058 |
|
35 |
29 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
34 |
34 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
26 |
$224.64 |
| 81002 |
|
74 |
70 |
$167.76 |